Patent · US Expired

7-methoxymethly-3-methyl-1-(5-oxohexyl)xanthine

US5710272A · kind A · utility

0Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateJan 20, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/911
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A Rhodotorula rubra strain has been found which reduces pentoxifylline to 100% to give the S-alcohol. Moreover, other oxoalkylxanthine derivatives can also be convened into the corresponding S-alcohol. The microbiologically obtained S-(+)-enantiomers can then be converted stereoselectively into the respective R-(-)-enantiomers. The corresponding S-alcohols and the R-alcohols obtained by enantioselective inversion of configuration cause an increase in cerebral blood flow.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.